HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

Following the mounting system and commercial losses that have become like a tidal wave of adversity on the books of the Electricity Company of Ghana (ECG), the government is considering privatizing ...

Samsung is reportedly working on a revolutionary feature in wearable technology: non-invasive blood glucose monitoring.

By taking action with your doctor, they can properly diagnosis health issues, and help develop an action plan for your life.

The Garmin Fenix 8 is a great smartwatch that excels at tracking numerous activities but doesn't quite measure up to other ...

A new national survey found that while many Americans use a device to monitor their heart, few share that data with their doctor.

Advances in technology have made it increasingly easier for people to self-monitor their heart health, whether it's via a ...

The Circular Ring 2 features an AFib detection system that should greatly help the device find its space in the smart ring ...

AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...

AI reveals hidden patterns in ECGs that human experts can't see, transforming a century-old clinical tool into a powerful ...